Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97ff9c9ed4e5c6dcec40edc3e2dd50dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ce63b6ac3d55d0156e0c412fcf8d783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b206d2ee8f09d8107a91765d8fde08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4ed47489aa0374793284b66ece15a9c |
publicationDate |
2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-107921099-A |
titleOfInvention |
Treating Type 2 Diabetics |
abstract |
A pharmaceutical combination for controlling blood sugar in patients with type 2 diabetes, said combination comprising (i) lixisenatide or/and pharmaceutically acceptable salts thereof, (ii) insulin glargine or/and pharmaceutically acceptable salts thereof and (iii) optionally metformin or/and pharmaceutically acceptable salts thereof. |
priorityDate |
2015-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |